INTRODUCTION
A burn is a lesion of organic tissues due to a trauma of thermal origin that varies
from a small bubble to severe forms that are capable of triggering systemic responses
proportional to lesion extent and depth1. Lesions can lead to disfiguration, disability and death2.
In the Brazilian public network, burns are locally treated with silver sulfadiazine ointment and daily or every other
day dressing changes in the vast majority of burn services3. In Europe, the United States, and some countries in South America, this same treatment is performed using human (allograft) or animal
(xenograft) skin3. In Brazil, there was never a record of animal skin use in the Brazilian Health Regulatory
Agency (ANVISA), nor was it available in the Brazilian National Health System for
use in burn patients.
According to the Ministry of Health, Brazil should have1 3 skin banks, but only four
are currently in working condition in São Paulo, Rio Grande do Sul, Paraná, and Rio
de Janeiro; together, they supply less than 1% of the skin needed throughout the country.
Without the use of skin, Brazil is 60 years behind in the treatment of local burns,
bringing to attention the fact that 97% of Brazilian burn victims do not have a health
plan4.
Tilapia is among the most consumed fish worldwide, including in Brazil, and the extensive
culture of this captive fish has given rise to the emergence of improved filets; in the production chain, everything is used (viscera, fish bone, and meat) except the skin, of which only 1% is used to produce
handicrafts. In 2011, plastic surgeon Dr. Marcelo Borges imagined the possibility
of using tilapia skin in the treatment of burns since the supply of skin for treating
burns in public hospitals is insufficient and costly.
In 2014, Dr. Edmar Maciel, a plastic surgeon from Ceará State, invited Dr. Marcelo
Borges and Ceará researcher Prof. Odorico Moraes to conduct this research in Ceará.
Once the initial team was created, the use of tilapia skin was initiated and the skin
was developed as an occlusive biological dressing for the treatment of burns, which
in turn resulted in the elaboration and implementation of the first Brazilian animal
skin bank, the subject of this work.
OBJECTIVE
To present the elaboration, development, and implementation of the first animal skin
bank of Brazil to treat burns.
METHODS
This methodological study started in 2015. The elaboration and development of the
animal skin bank are directly associated with tilapia skin development prior to and
together with implementation of the aquatic animal skin bank itself, and several stages
were performed in the development and establishment of the tilapia skin production
process.
Captivity Study
Several visits were conducted by the research team to fish farms in Jaguaribara -
Ceará, aiming to discern and study tilapia production, including the establishment
of a location for processing and cleaning the skin.
Healing Laboratory Assembly
The Healing Laboratory was constructed in 2015 to produce tilapia skin for future
use in animal and human studies. This laboratory is also located in the Nucleus of
Research and Development of Medicines of Ceará (NPDM), where the same processes were
established in human skin tissues banks for the cleaning, sterilizing, and wrapping
of tilapia skin.
Pre-clinical Studies Implementation
Several studies were conducted in 2015 and 2016 with the intent of evaluating the histology, safety, and efficiency of tilapia skin, including a
histological study to compare tilapia skin with animal skin5, tilapia microbiota study6, microbiological test in all stages of tilapia skin preparation, application of tilapia
in rats7, comparative histological study of irradiated skin8, skin toxicity study, laboratory study in animals after skin application, and histological
study of healing.
Patent Registration
In 2015, a patent for tilapia skin was registered at the National Institute of Industrial Property (no. BR1020150214359). Abroad, the
patent registration was performed in 2016 (no. 00002216016690245).
Animal Skin Bank
At the same time, the following stages were developed for the animal skin bank implementation:
Bibliographical survey: The bibliographic survey was conducted by consulting national and international literature
within the PUBMED and Latin American and Caribbean Health Sciences Literature databases.
The following resolutions of the ANVISA were used: Resolution of the Collegiate Board
RDC no. 220 of December 27, 2006; and Resolution of the Collegiate Board RDC no. 55
of December 11, 2015. The following descriptors were used in the search: good practices,
skin banks, protocols, and flowcharts. The study’s inclusion criteria were published
in Portuguese, Spanish, or English in books and indexed in the selected databases
with the descriptors listed above.
Recognition of the physical area for the animal skin bank assembly: Using the site’s ground plan, a survey was performed of all available areas for animal skin processing in which the locations for each processing stage were
selected, to establish a continuous flow. A survey of all equipment available on site
was also conducted.
Visits to human skin banks: Technical visits were made to skin banks in Recife-PE, Curitiba-PR, São Paulo-SP,
Rio de Janeiro-RJ, and Porto Alegre-RS, in which a needs survey of input, sterilization
control, and organization of the environment was conducted.
Technical consultant: The head nurse of the Skin Bank in Recife - Professor Fernando Figueira Institute
of Integral Medicine was hired as a technical consultant in Fortaleza and subsequently
attended an immersion (hands on) session on the chemical sterilization process of
tilapia skin in Recife.
Establishment of the sterilization process: After chemical sterilization of some batches of tilapia skin, the researchers visited
the Institute of Nuclear Energy Research and, through a research partnership, began
the irradiation process after chemical sterilization. To reach the current stage of
tilapia skin sterilization, several evaluations with different chlorhexidine and glycerol
concentrations and irradiation dosages were required.
Registration and standardization of tilapia skin processes: In this stage, an observational follow-up of the tilapia skin production process
was performed from the animal’s slaughter in Jaguaribara-CE to skin wrapping in the
laminar flow. All processes were recorded in documents and through photographs.
Figure 1 shows the implemented stages up for the creation of the skin bank.
Figure 1 - Timeline of the elaboration, development, and implementation of the animal skin bank.
Figure 1 - Timeline of the elaboration, development, and implementation of the animal skin bank.
RESULTS
The Aquatic Animal Skin Bank of the NPDM located at the Federal University of Ceará,
in Fortaleza, has been operating since 2016 and was inaugurated in 2017. Its first
production run included 250 skins. In addition to producing and distributing tilapia skin for the studies of burn victims, the bank has processed more than 5000 Nile
tilapia skins (Oreochromis niloticus) and is in the skin distribution phase for multilevel studies in other states (SP,
GO, PR, and PE) and other specialties including gynecology, orthopedics, endoscopy,
stomatherapy, vascular surgery, dentistry, and veterinary medicine for the reconstruction
of vaginas, varicose ulcers, pressure wounds, and dog wounds as well as in experimental
animal studies as a possible scaffold.
The Bank team consists of an administrative medical director, technical medical director,
chief nurse, two nurses, nursing technicians and assistants, and medical and nursing
students.
The physical space includes two clean rooms with laminar flow for the tilapia skin
sterilization process following the classification standards required by the ANVISA
for human studies.
Standardization of tilapia skin processing
The tilapia skin improvement process is divided into seven stages:
Stage 0 - Organization and assembly of the Healing Laboratory and the Animal Skin
Bank before the arrival of the skins;
Stage 1 - Processing and transport: Ensuring proper collection of skins at fish farms
and transporting them in isothermal boxes to the laboratory;
Stage 2 - Cleaning and decontamination: Cleaning and withdrawal of excess dermal muscle
and clipping of skin borders;
Stage 3 - 2% chlorhexidine decontamination;
Stage 4 - Chemical sterilization in 75% glycerol;
Stage 5 - Sterilization in 100% glycerol in a water bath; and
Stage 6 - Double wrapping, double sealing, labeling, and inventory (performed in the
laminar flow cabin).
From Stage 6, the processed and identified skins are conserved under refrigeration
at 2-4°C in a refrigerator designated for non-released tissues awaiting the microbiological
result. These skins are identified and catalogued using Cartesian numbering in ascending order and sent to the Institute of Nuclear Energy
Research in São Paulo, where they are irradiated to 30 kGy and sent back to the laboratory
of origin (Healing Laboratory - NPDM), where they are stored in a refrigerator for
released tissue for use at 2-4°C. After these stages, the skins are valid for use
for up to 2 years.
Some of the processing stages are shown in Figures 2a and 2b.
Figure 2 - A Cleaning and preparation of the tilapia skin by the responsible team.
Figure 2 - A Cleaning and preparation of the tilapia skin by the responsible team.
Figure 2 - B Tilapia skin prepared and packed by the team.
Figure 2 - B Tilapia skin prepared and packed by the team.
After obtaining the tilapia skin with double wrapping, the researchers were not satisfied;
to facilitate transportation to other states and countries, besides decreasing the cost since it is meant to be a product that can be on the
shelf, they developed lyophilized tilapia skin.
Another completed stage is the removal of skin cells from the tilapia for use as an acellular dermal matrix of a sling and scaffold in diverse areas. As soon as animal studies are completed, this scaffold can be used in numerous medical specialties, such as gynecology (uterine and bladder
lifting and pelvic floor repair), plastic surgery (breast reconstruction and fat grafting),
general surgery (hernias), traumatology (tendon injuries), and tissue loss.
The Aquatic Animal Skin Bank is in the documentary preparation phase, in which protocols,
flowcharts referring to each processing stage, checklists, and a flowchart map are
developed, to standardize all procedures and verify if they are being complied with
as recommended. Hence, the researchers ensured that the facility met regulatory standards
to facilitate the installation process of future aquatic skin banks that can be installed
in the country and abroad.
DISCUSSION
Information about the use of cadaver skin in the literature was first published in
19039 by Wentscher, who kept the skin refrigerated for 7 days. Conversely, the first record
of animal skin use was published in 195210 by Keeley, who conducted and published an experimental study with dog skin, showing
the effects of freezing, vitrification, and dehydration. In 1955, James Barret Brown11 laid the foundation for organizing a skin bank in terms of physical structure and
skin conservation methods.
In Brazil, the first skin bank was established in the 1980s, functioning in the early
stages at the Clinical Hospital (HC) in São Paulo. The current HC skin bank was created
in 2000, renovated in 2006, and reopened in 2012. Unfortunately, the amount of skin
provided by skin banks that are currently operating in Brazil falls far short of the
requirement for burn treatment.
Since its inception, the Aquatic Animal Skin Bank of the NPDM has processed more than
5000 Nile tilapia (Oreochromis niloticus) skins. It is becoming an increasingly more viable option to meet the country’s skin
demand in the treatment of burns, as research has shown positive results in various
clinical settings. The raw material is a byproduct of tilapia processing and presents
another advantage of being less costly than conventional silver sulfadiazine treatment.
Given this point of view, the Aquatic Animal Skin Bank must comply with the regulatory
standards required by the regulatory agencies since the ANVISA abides by the Collegiate
Board Resolution RDC no. 55 of December 11, 201512, which provides Good Human Tissue Practices for therapeutic use as a guideline to
ensure tissue quality and safety for therapeutic use. This applies to all tissue banks
of any nature that perform activities with one or more types of human tissue for therapeutic
purposes13. Given this, because it is a tissue with applicability in humans, the release and
use of tilapia skin is subjected to strict protocols to ensure the recipient’s health.
The challenges to the first Brazilian Aquatic Animal Skin Bank involves adapting established
rules for human donor skin banks to process skin extraction from an animal, mainly
because it is a novel concept in Brazil, where it will probably be used as a standard
model to be replicated domestically and internationally.
Finally, in addition to the innovation in the development of an invaluable clinical
use product derived from tilapia processing, its initial objective of fulfilling the
demand for skin for burn treatments has now a large array of possibilities. In terms
of the therapeutic applicability of tilapia skin, the results of this work also place
Brazil in a prominent position as a pioneer in the production of this type of material
and the first country to have an aquatic animal skin bank.
CONCLUSION
This work allowed the creation of Brazil’s first animal skin bank with structure,
elaboration, and standardization of all procedures for the production of tilapia skin.
COLLABORATIONS
EMLJ
|
Data Curation, Final manuscript approval, Funding Acquisition, Investigation, Project
Administration, Realization of operations and/or trials, Supervision
|
MOMF
|
Conception and design study, Project Administration, Supervision
|
MBSR
|
Final manuscript approval, Supervision, Writing - Original Draft Preparation, Writing
- Review & Editing
|
FRSJ
|
Data Curation, Realization of operations and/or trials
|
CMPL
|
Data Curation, Realization of operations and/or trials
|
MFAN
|
Data Curation, Realization of operations and/or trials
|
REFERENCES
1. Guirro E, Guirro R. Queimaduras. In: Fisioterapia dermatofuncional: fundamentos, recurso
e patologias. São Paulo: Manole; 2004. p.491-7.
2. Lima Júnior EM, Novaes FN, Piccolo NS, Serra, MCVF. Tratado de queimaduras no paciente
agudo. 2a ed. São Paulo: Atheneu; 2008.
3. Lima Júnior EM. Tecnologias inovadoras: uso da pele da tilápia do Nilo no tratamento
de queimaduras e feridas. Rev Bras Queimaduras. 2017;16(1):1-2.
4. Lima Júnior EM. Rotina de atendimento ao queimado. Fortaleza: Gráfica LCR; 2009.
5. Alves APNN, Verde MEQL, Ferreira Júnior AEC, Silva PGB, Feitosa VP, Lima Júnior EM,
et al. Avaliação microscópica, estudo histoquímico e análise de propriedades tensiométricas
da pele de tilápia do Nilo. Rev Bras Queimaduras. 2015;14(3):203-10.
6. Lima Júnior EM, Bandeira TJPG, Miranda MJB, Ferreira GE, Parente EA, Piccolo NS, Moraes
Filho MO. Characterization of the microbiota of the skin and oral cavity of Oreochromis
niloticus. J Health Biol Sci. 2016;4(3):193-7. DOI: 10.12662/2317-3076jhbs.v4i3.767.p193-197.2016
7. Lima Júnior EM, Picollo NS, Miranda MJB, Ribeiro WLC, Alves APNN, Ferreira GE, et
al. Uso da pele de tilápia (Oreochromis niloticus), como curativo biológico oclusivo,
no tratamento de queimaduras. Rev Bras Queimaduras. 2017;16(1):10-7.
8. Alves APNN, Lima Júnior EM, Piccolo NS, de Miranda MJB, Lima Verde MEQ, Ferreira Júnior
AEC, et al. Study of tensiometric properties, microbiological and collagen content
in nile tilapia skin submitted to different sterilization methods. Cell Tissue Bank.
2018 Sep;19(3):373-382. DOI: 10.1007/s10561-017-9681-y DOI: https://doi.org/10.1007/s10561-017-9681-y
9. Wentscher J. Ein weiterer Beitrag zur Überlebensfähigkeit der menschlichen Epidermiszellen.
Dtsch Z Chir. 1903;70:21-44. DOI: https://doi.org/10.1007/BF02790822
10. Keeley RLA, Gomez AC, Brown Júnior IW. An experimental study of the effects of freezing,
partial dehydration and ultra-rapid cooling on the survival of dog skin grafts. Plast
Reconstr Surg. 1952 Apr;9(4):330-344.
11. Allgower M, Blocker Júnior TG. Viability of skin in relation to various methods of
storage. Tex Rep Biol Med. 1952;10(1):3-21.
12. Ministério da Saúde (BR). Agência Nacional de Vigilância Sanitária (ANVISA). Resolução
da diretoria colegiada - RDC n° 55, de 11 de dezembro de 2015. Dispõe sobre as Boas
Práticas em Tecidos humanos para uso terapêutico. Diário Oficial da União, Brasília
(DF). 14 dez 2015 [acesso em 13 mar 2018]. Disponível em: http://www.cevs.rs.gov.br/upload/arquivos/201705/18112318-rdc-55-2015-boas-praticas-em-tecidos-14-12-2015.pdf
13. Ministério da Saúde (BR). Agência Nacional de Vigilância Sanitária (ANVISA). Relatório
de Avaliação dos Dados de Produção dos Bancos de Tecidos - Ano 2016, Brasil. Brasília
(DF): ANVISA; 2016 [acesso em 13 mar 2018]. Disponível em: http://portal.anvisa.gov.br/documents/33840/2818486/Relat%C3%B3rio+de+Aalia%C3%A7%C3%A3o+dos+Dados+de+Produ%C3%A7%C3%A3o+dos+Bancos+de+Tecidos+%E2%80%93+2016/dd27517b-f3fe-4531-8f4638a24586100c
1. Instituto José Frota, Fortaleza, CE, Brazil.
2. Universidade Federal do Ceará, Fortaleza, CE, Brazil.
Corresponding author: Edmar Maciel Lima Júnior Rua Visconde de Mauá, 1650, Ap. 801, Fortaleza, CE, Brazil. Zip Code: 60125-160.
E-mail: edmarmaciel@gmail.com
Article received: January 23, 2019.
Article accepted: June 22, 2019.
Conflicts of interest: none.